ACETO Corporation Announces the Pricing of Its $125 Million Convertible Notes Offering
November 11, 2015 00:34 ET
|
Aceto Corporation
PORT WASHINGTON, N.Y., Nov. 11, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET) today announced the pricing of $125 million aggregate principal amount of convertible senior notes due 2020...
ACETO Corporation Announces $125 Million Convertible Notes Offering
November 09, 2015 16:18 ET
|
Aceto Corporation
PORT WASHINGTON, N.Y., Nov. 9, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET) today announced its intention to offer, subject to market conditions and other factors, $125,000,000 aggregate...
ACETO Reports Fiscal 2016 First Quarter Results
November 05, 2015 17:00 ET
|
Aceto Corporation
PORT WASHINGTON, N.Y., Nov. 5, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), focused on the global marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and...
ACETO Corporation Schedules First Quarter & Fiscal 2016 Financial Results News Release and Conference Call
October 23, 2015 16:00 ET
|
Aceto Corporation
PORT WASHINGTON, N.Y., Oct. 23, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients...
ACETO Files Shelf Registration Statement
October 14, 2015 08:30 ET
|
Aceto Corporation
PORT WASHINGTON, N.Y., Oct. 14, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), a global leader in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients...
ACETO Subsidiary, Rising Pharmaceuticals, to Launch Glycopyrrolate Tablets and Methimazole Tablets
October 02, 2015 08:20 ET
|
Aceto Corporation
PORT WASHINGTON, N.Y., Oct. 2, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), a global leader in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients...
ACETO Subsidiary, Rising Pharmaceuticals, Acquires Three FDA-Approved ANDAs From Endo International plc
September 28, 2015 08:00 ET
|
Aceto Corporation
PORT WASHINGTON, N.Y., Sept. 28, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical...
ACETO Subsidiary, Rising Pharmaceuticals, Acquires Three FDA-Approved Ophthalmic ANDAs From Nexus Pharmaceuticals
September 15, 2015 09:12 ET
|
Aceto Corporation
PORT WASHINGTON, N.Y., Sept. 15, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical...
ACETO Reports Fiscal 2015 Fourth Quarter and Year End Results
September 10, 2015 17:00 ET
|
Aceto Corporation
PORT WASHINGTON, N.Y., Sept. 10, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical...
ACETO Board of Directors Declares Quarterly Cash Dividend
September 10, 2015 14:36 ET
|
Aceto Corporation
PORT WASHINGTON, N.Y., Sept. 10, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical...